drugset / Trial / NCT00780832

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

NCT00780832

Terminated 8 enrolled IWK Health Centre
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the effects of caffeine reduction/elimination on urinary symptoms in women with overactive bladders and compare this therapeutic approach to anticholinergic therapy. We hope to show a reduction in symptoms with caffeine reduction and determine how effective caffeine reduction is compared to medication. If caffeine reduction is shown to be beneficial, women may be encouraged to use this strategy before resorting to medications.

Timeline

Start
2008-05
Primary completion
2012-12
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolterodine Small molecule 4 mg Oral

Indications